Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03683394 · ClinicalTrials.gov registry record · NA
Systematic Multi-domain Alzheimer's Risk Reduction Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT03683394 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 172 participants.
The verdict
NCT03683394, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
The primary goal of this randomized controlled trial (RCT) is to pilot-test a personalized, pragmatic, multi-domain Alzheimer's disease risk reduction intervention in a U.S. integrated healthcare delivery system.
Interventions
- BEHAVIORAL Health Education Intervention
- BEHAVIORAL SMARRT Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2018-08-30 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03683394
The ClinicalTrials.gov registry entry for NCT03683394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education Intervention is the first listed.
NCT03683394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03683394 about?
NCT03683394 is a clinical study titled "Systematic Multi-domain Alzheimer's Risk Reduction Trial". The primary goal of this randomized controlled trial (RCT) is to pilot-test a personalized, pragmatic, multi-domain Alzheimer's disease risk reduction intervention in a U.S. integrated healthcare delivery system.
What is the current status of trial NCT03683394?
This trial is currently completed. It is a NA study. The enrollment target is 172 participants. The study started on 2018-08-30. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT03683394?
The interventions under investigation include: Health Education Intervention (BEHAVIORAL), SMARRT Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03683394?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.